Recent Advances on Bacterial Cellulose-Based Wound Management: Promises and Challenges

Table 5

The wound healing rate of BC-based wound dressing.

Wound dressing	BC wound healing rate (%)	Modified BC wound healing rate (%)	Control	Reference
BC/thymol	74.5	90	60	[111]
BC/PDA/PAM	N/A	100	85.7	[196]
BC/chitosan	96	98	91	[110]
RBC/amoxicillin	80	100	65	[169]
BC/DAPT-Au	65	88	65	[168]
BC/TiO2	49.14	71	73.71	[163]
BC/Cu-MMT	38.75	75.08	76.01	[179]
BC/PHMB/silk sericin	N/A	100	92	[178]
BC/PHMB-PBC	57.1	96.9	57.1	[100]
BC/PHMB-PBC	57.1	96.9	57.1	[100]
rBC/MXene/EF	76	93.8	87	[121]
BC/P(3HB/4HB)/actovegin	N/A	92.7	69.4	[102]
BC/P(3HB/4HB)/fibroblast	N/A	91	69.4	[102]
BC/ZnO	50.51	65.3	77.1	[33]
BC/PDA	74.58	94.35	65.35	[108]
BC/gel/Met	N/A	53.4	45	[172]
BC/gel/Gb	N/A	62.69	45	[172]
BD/Gly-DMAPA/si-MMP-9	59.88	74.07	45.28	[192]
CNF/G/Ag	40	80	40	[107]
BC/SSD	N/A	92.35	78.83	[165]
BC/Ag NP	60.77	85.92	43.39	[166]
BC/curcumin	41.60	64.25	30	[182]
BC/MZA	64.40	97.70	64.40	[124]
BC/Zingiber officinale	80	68	65	[187]

Controls: honey [187], untreated burn wound [124], silver sulfadiazine [182], untreated (gauze) [166], gauze [165], CNF[107], diabetic rat [192], untreated wound burn [172], untreated wound burn [108], silver sulfadiazine wounds [33], VoskoPran commercial dressing [102], commercial Tegaderm film dressing [121], pure BC membrane [100], commercial Bactigras wound dressing [178], silver sulfadiazine cream [179], silver sulfadiazine [163], pure BC [168]; untreated wound burn [169], pure BC [110], untreated wound burn [196], and untreated [111].